Evaluating the Efficacy of Suture Mesh vs. Planar Mesh in Ventral Hernia Treatment

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRegionshospital Nordjylland

About this trial

The goal of this clinical trial is to investigate whether mesh-suture affects wound complication rates, patient-reported quality of life, and operation time in adult patients undergoing surgery for small ventral hernias.

The main questions it aims to answer are:

Does mesh-suture reduce wound complication rates compared to planar mesh? Does mesh-suture improve patient-reported quality of life(QoL) and affect operation time compared to planar mesh?

Comparison group:

Researchers will compare standard treatment with planar mesh to the interventional treatment with mesh-suture to see whether mesh-suture leads to fewer complications, better quality of life, and shorter operation time.

Participants will:

Be randomized to receive either planar mesh or mesh-suture during hernia repair surgery.

Undergo standardized preoperative assessment, including baseline data and QoL scoring.

Attend a postoperative visit on day 7-13 for wound inspection and ultrasound. Complete QoL assessments at 90 days (telephone follow-up). Have operation time recorded and medical records reviewed for readmissions within 90 days.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Ventral hernia (maximum size 3 × 3 cm) measured with Ultrasound or CT.

Participants must be eligible for surgical repair using either mesh-suture or planar mesh

Disqualifiers

Age < 18 years.

Acute (emergent) operation.

Pregnancy.

Women with plans for future pregnancies.

Trial design

Design model

Parallel

Treatments tested in this trial

  • mesh suture

    Device

    mesh suture

  • planar mesh

    Device

    planar mesh

Treatment groups

280 Participants
are divided into 2 treatment groups
Group A: mesh sutureExperimental treatment 1 intervention
Group B: planar meshActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Surgical Site Occurrences (SSO) Assessed by Clinical Examination and Ultrasound

Definition: We will apply the standardized CDC (Centers for Disease Control and Prevention ) and VHWG (Ventral Hernia Working Group) definitions for SSO. Evaluation: Clinical examination. Additionally, an ultrasound examination will be performed.

Time frame
7-13 days after operation

Secondary outcomes

1

Abdominal Hernia-Q Questionnaire

Scale description: Disease-specific patient-reported outcome measure for abdominal hernia symptoms and quality of life. Score range: Each domain ranges from 1 to 4, where higher scores indicate better health status and fewer symptoms.

Time frame
preoperative, postoperative day 10, day 90
2

EQ-5D-5L Index Score

Scale description: Generic health-related quality-of-life instrument assessing five dimensions of health. Score range: The Index Score ranges from \< 0 (worst health state, depending on country value set) to 1 (perfect health) and

Time frame
preoperative, postoperative day 10, day 90
3

EQ-VAS (Visual Analogue Scale)

Patients rate their overall health on a vertical scale from 0 to 100. Interpretation: Higher scores indicate better overall health-related quality of life.

Time frame
preoperative, postoperative day 10, day 90
4

DURATION OF SURGERY

Operation time measured in minutes

Time frame
The time interval from the first incision to the last stitch is set

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.